Linking evidence-based medicine therapeutic summary measures to clinical decision analysis.

Publication Type:

Journal Article

Source:

MedGenMed : Medscape general medicine, Volume 2, Issue 1, p.E6 (2000)

Keywords:

Aged, Algorithms, Antineoplastic Agents, Breast Neoplasms, Chemotherapy, Adjuvant, Decision Support Systems, Clinical, Decision Support Techniques, Evidence-Based Medicine, Female, Humans, Middle Aged, Outcome Assessment (Health Care), Quality Assurance, Health Care, RISK, Sensitivity and Specificity, Stroke, Treatment Outcome

Abstract:

Evidence-based medicine (EBM) seeks to improve clinical practice by evaluating the quality of clinical evidence and ensuring that only the "best" evidence from clinical research is used in the management of individual patients. EBM has contributed to our understanding of the meaning of the benefit and harm of treatment as reported in the literature, and it is often promoted as an aid to clinical decision making. However, EBM therapeutic summary measures reflect only a single dimension of clinical decision making. The purpose of this work is to show how EBM therapeutic summary measures can be effectively incorporated into medical decision making.